| Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours. | breast, |
| Prognostic contribution of the HER-2 oncogene overexpression to the Nottingham Prognostic Index in breast cancer. | breast, |
| Lack of c-erbB-2 oncoprotein expression in male breast carcinoma. | breast, |
| [Development of sandwich radioimmunometric assay for serum c-erbB-2 oncogene product and its significance in diagnosing breast carcinoma]. | breast, |
| Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance. | breast, |
| A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas. | HNSC, |
| Nuclear and flow cytometric characteristics associated with overexpression of the c-erbB-2 oncoprotein in breast carcinoma. | breast, |
| Use of immunohistochemically demonstrated c-erb B-2 oncoprotein expression as a prognostic factor in transitional cell carcinoma of the urinary bladder. | bladder, |
| HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. | colorectal, |
| [Comparision of HER2/neu oncogene detected by chromogenic in-situ hybridization and immunohistochemistry in breast cancer]. | breast, |
| c-erbB-2 oncoprotein over-expression in breast cancer and its relationship to histology and grade in a Ugandan population. | breast, |
| Different expression of HER2/neu oncogene in breast carcinoma and in liver metastasis. Description of a case. | liver,breast, |
| The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272. | lung, |
| [Role of Ki-67, mutated gene-suppressor p53 and HER-2neu oncoprotein in the prognosis for the clinical course of bladder cancer]. | bladder, |
| A new hypothesis on the role of c-erbB2 oncogene in the progress of breast cancer. | breast, |
| Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. | colorectal, |
| Predicted B-cell epitopes of HER-2 oncoprotein by a bioinformatics method: a clue for breast cancer vaccine development. | breast, |
| HER-2/neu expression in glioblastoma multiforme. | glioblastoma, |
| FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. | breast, |
| [Activation of erbB-2 oncogene and prognosis of the course of human breast cancer]. | breast, |